An Advanced Data analytics company
We serve the engagement planning needs of global pharmaceutical, biotechnology, and medical device companies.
81qd, an advanced health care data analytics company, provides life sciences organizations with customized, cost-effective solutions designed to maximize their brands’ commercial potential through all stages of product development and commercialization. Our name comes from the smallest effective dosage of aspirin for preventing heart attack and stroke—81 mg every day—and it exemplifies our mission of providing high-value, cost-effective solutions.
Our multidisciplinary team of data scientists, medical strategists, and marketing professionals has decades of experience in health care analytics. 81qd is differentiated by our ability to provide end-to-end solutions, from strategic planning to tactical execution. We are at the forefront of the latest advances in data science, which power our proprietary solutions to solve our clients’ business challenges.
Our clinical network mapping solution harnesses the power of machine learning and real-world data to identify the true clinical leaders within communities—those individuals who impact the care of patients far beyond their own practice. This provides our clients the competitive advantage of being able to leverage clinical leaders in a specific disease state to drive the diffusion of medical innovation to improve patient outcomes. 81qd’s clients use the customized, brand-specific output to accelerate product adoption, improve sales effectiveness, enhance market access, and increase sales volume.
Our patient-finding solution utilizes predictive analytics to identify specific clinicians currently managing yet-to-be-diagnosed patients with diseases that are difficult to diagnose. This proprietary solution leverages machine learning and computational statistics to analyze disparate sources of data—including medical claims data, pharmacy claims data, laboratory data, and electronic health records—to reliably predict which patients have the highest probability of having a particular difficult-to-diagnose disease.
Our global stakeholder management platform employs industry-leading methodologies for data mining, cleansing, and disambiguation to identify and profile clinicians from an academic and scientific perspective.